{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:19:47Z","timestamp":1790104787264,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Robert Koch Institute"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijmm.2019.151336","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T15:58:08Z","timestamp":1565971088000},"page":"151336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017"],"prefix":"10.1016","volume":"309","author":[{"given":"Regina","family":"Selb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidmante","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hogardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Sedlacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny A.","family":"Idelevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren L.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus P.","family":"K\u00fcpper-Tetzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"McCormick-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Gerkrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ok","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunja","family":"Wilmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Rickerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2019.151336_bib0005","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1128\/AAC.44.6.1544-1548.2000","article-title":"Correlation of fluconazole MICs with clinical outcome in cryptococcal infection","volume":"44","author":"Aller","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2019.151336_bib0010","first-page":"62","article-title":"Environmental triazole induces cross-resistance to clinical drugs and affects morphophysiology and virulence of Cryptococcus gattii and C. neoformans","author":"Bastos","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2019.151336_bib0015","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3389\/fmicb.2017.01024","article-title":"Azole resistance in aspergillus fumigatus: a consequence of antifungal use in agriculture?","volume":"8","author":"Berger","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0020","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution","volume":"43","author":"Bicanic","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijmm.2019.151336_bib0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/myc.12747","article-title":"A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species","volume":"61","author":"Bongomin","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.ijmm.2019.151336_bib0030","first-page":"62","article-title":"Roles of three Cryptococcus neoformans and Cryptococcus gattii efflux pump-coding genes in response to drug treatment","author":"Chang","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2019.151336_bib0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12879-015-1023-8","article-title":"Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijmm.2019.151336_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fgb.2019.04.001","article-title":"Genotypes and population genetics of Cryptococcus neoformans and Cryptococcus gattii species complexes in Europe and the Mediterranean Area","volume":"129","author":"Cogliati","year":"2019","journal-title":"Fungal Genet. Biol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.fgb.2016.01.003","article-title":"Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. Neoformans is a recombinant population","volume":"87","author":"Cogliati","year":"2016","journal-title":"Fungal Genet. Biol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0050","series-title":"European Centre for Disease Prevention and Control, Stockholm. Risk Assessment on the Impact of Environmental Usage of Triazoles on the Development and Spread of Resistance to Medical Triazoles in Aspergillus species","author":"ECDC","year":"2013"},{"key":"10.1016\/j.ijmm.2019.151336_bib0055","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1128\/AAC.01115-12","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole","volume":"56","author":"Espinel-Ingroff","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2019.151336_bib0060","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/AAC.06252-11","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine","volume":"56","author":"Espinel-Ingroff","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"887","key":"10.1016\/j.ijmm.2019.151336_bib0065","first-page":"e881","article-title":"Predominance of Cryptococcus neoformans var. Grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in China","volume":"22","author":"Fan","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijmm.2019.151336_bib0070","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1128\/JCM.00064-13","article-title":"Development of a singleplex PCR assay for rapid identification and differentiation of Cryptococcus neoformans var. grubii, Cryptococcus neoformans var. neoformans, Cryptococcus gattii, and hybrids","volume":"51","author":"Feng","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005223","article-title":"MLST-based population genetic analysis in a global context reveals clonality amongst Cryptococcus neoformans var. Grubii VNI isolates from HIV patients in Southeastern Brazil","volume":"11","author":"Ferreira-Paim","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijmm.2019.151336_bib0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/myc.12543","article-title":"Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain","volume":"60","author":"Gago","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.ijmm.2019.151336_bib0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","article-title":"Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex","volume":"78","author":"Hagen","year":"2015","journal-title":"Fungal Genet. Biol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0090","first-page":"2","article-title":"Importance of resolving fungal nomenclature: the case of multiple pathogenic species in the Cryptococcus genus","author":"Hagen","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.ijmm.2019.151336_bib0095","first-page":"2","article-title":"The case for adopting the \"Species complex\" nomenclature for the etiologic agents of cryptococcosis","author":"Kwon-Chung","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.ijmm.2019.151336_bib0100","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/jac\/dkt221","article-title":"Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal","volume":"68","author":"Loyse","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijmm.2019.151336_bib0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: from environmental saprophyte to global pathogen","volume":"14","author":"May","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/13693780902953886","article-title":"Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii","volume":"47","author":"Meyer","year":"2009","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/345956","article-title":"Primary cutaneous cryptococcosis: a distinct clinical entity","volume":"36","author":"Neuville","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijmm.2019.151336_bib0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fgb.2014.10.003","article-title":"Cryptococcosis diagnosis and treatment: what do we know now","volume":"78","author":"Perfect","year":"2015","journal-title":"Fungal Genet. Biol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijmm.2019.151336_bib0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.diagmicrobio.2011.07.007","article-title":"Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method","volume":"71","author":"Pfaller","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijmm.2019.151336_bib0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/22221751.2018.1562849","article-title":"Genotypic diversity and clinical outcome of cryptococcosis in renal transplant recipients in Brazil","volume":"8","author":"Ponzio","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ijmm.2019.151336_bib0140","first-page":"10","article-title":"Evolution of fluconazole-resistant Candida albicans strains by drug-induced mating competence and parasexual recombination","author":"Popp","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.ijmm.2019.151336_bib0145","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijmm.2019.151336_bib0150","series-title":"Conference on Retroviruses and Opportunistic Infections; March 4-7 2018","article-title":"Adjunctive sertraline in HIV-associated cryptococcal meningitis [abstract]","author":"Rhein","year":"2018"},{"key":"10.1016\/j.ijmm.2019.151336_bib0155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","volume":"16","author":"Rhein","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijmm.2019.151336_bib0160","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/AAC.47.11.3653-3656.2003","article-title":"G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate","volume":"47","author":"Rodero","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2019.151336_bib0165","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1038\/s41467-018-04926-x","article-title":"Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijmm.2019.151336_bib0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00430-014-0341-6","article-title":"Molecular typing of clinical Cryptococcus neoformans isolates collected in Germany from 2004 to 2010","volume":"203","author":"Sanchini","year":"2014","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0175","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/AAC.05502-11","article-title":"Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14alpha-demethylase (Erg11) residue critical for differential susceptibility between fluconazole\/voriconazole and itraconazole\/posaconazole","volume":"56","author":"Sionov","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2019.151336_bib0180","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/AAC.00295-09","article-title":"Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence","volume":"53","author":"Sionov","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2019.151336_bib0185","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijmm.2015.08.023","article-title":"Cryptococcosis due to Cryptococcus gattii in Germany from 2004-2013","volume":"305","author":"Smith","year":"2015","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0190","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1128\/AAC.01299-15","article-title":"Increased antifungal drug resistance in clinical isolates of Cryptococcus neoformans in Uganda","volume":"59","author":"Smith","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2019.151336_bib0195","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI124516","article-title":"Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis","volume":"129","author":"Stone","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijmm.2019.151336_bib0200","article-title":"Multilocus sequence typing of Cryptococcus neoformans var. Grubii from Laos in a regional and global context","author":"Thanh","year":"2018","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ijmm.2019.151336_bib0205","first-page":"3","article-title":"Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis","author":"Wiesner","year":"2012","journal-title":"mBio"},{"key":"10.1016\/j.ijmm.2019.151336_bib0210","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422119302450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422119302450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T07:15:10Z","timestamp":1566976510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422119302450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1438422119302450"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2019.151336","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2019.151336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151336"}}